Ligand Pharmaceuticals Stock Price - LGND

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Ligand Pharmaceuticals Incorporated LGND NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
2.10 1.75% 122.00 120.62 124.965 123.20 119.90 00:00:10
Bid Price Ask Price Spread Spread % News
58.00 149.75 91.75 61.27% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
7,108 346,270 $ 122.38 $ 42,375,757 375,115 57.24 - 124.965
Last Trade Time Type Quantity Stock Price Currency
16:53:03 priorref 2,662 $ 122.00 USD

Ligand Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.96B 16.05M 14.58M $ 120.28M $ -66.91M 30.33 -29.26
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 5.00 9.10%

more financials information »

Ligand Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LGND Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week100.49124.96597.3975112.42445,77221.5121.41%
1 Month104.92124.96592.04105.44368,03417.0816.28%
3 Months85.98124.96557.2487.36485,09736.0241.89%
6 Months107.60124.96557.2492.23432,96714.4013.38%
1 Year115.32124.96557.2497.27399,2536.685.79%
3 Years111.89278.6257.24135.99391,50010.119.04%
5 Years92.38278.6257.24124.89366,77829.6232.06%

Ligand Pharmaceuticals Description

Ligand Pharmaceuticals is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Your Recent History
Ligand Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.